Transforming the future of renal care
We understand that nephrology faces the challenge of providing effective responses in the treatment of renal diseases, especially in their predialytic phases. This challenge is reflected in the increasing incidence of patients progressing to end-stage renal disease (ESRD), with the consequent need for dialysis.
Our commitment is to lead a significant change in this landscape through clinical research to improve the care and treatment of chronic kidney disease (CKD). Our active participation in national and international research projects allows us to be at the forefront in the development of new strategies and treatments that benefit our patients and transform the future in RENAL HEALTH FOR ALL.
At Renálida, we conduct innovative clinical studies covering a wide range of designs, from descriptive and analytical to experimental. We specialize in both pharmacological and non-pharmacological clinical trials, generating knowledge that contributes to slowing the progression of renal diseases, improving the quality of life of our patients and the continuous improvement of our services.
Transforming the future of renal care
We understand that nephrology faces the challenge of providing effective responses in the treatment of renal diseases, especially in their predialytic phases. This challenge is reflected in the increasing incidence of patients progressing to end-stage renal disease (ESRD), with the consequent need for dialysis.
Our commitment is to lead a significant change in this landscape through clinical research to improve the care and treatment of chronic kidney disease (CKD). Our active participation in national and international research projects allows us to be at the forefront in the development of new strategies and treatments that benefit our patients and transform the future in RENAL HEALTH FOR ALL.
At Renálida, we conduct innovative clinical studies covering a wide range of designs, from descriptive and analytical to experimental. We specialize in both pharmacological and non-pharmacological clinical trials, generating knowledge that contributes to slowing the progression of renal diseases, improving the quality of life of our patients and the continuous improvement of our services.
Compromiso con la Excelencia en Investigación Clínica
A través de la participación de la Dra. Paula Marioli como miembro del Comité de Ensayos Clínicos de la Sociedad Internacional de Nefrología (ISN-ACT) contribuimos a fortalecer la capacidad de la comunidad global de nefrología para liderar y participar en ensayos clínicos. Esta colaboración nos permite no solo mejorar la calidad de los ensayos clínicos en los que participamos, sino también compartir nuestra experiencia y aprender de los principales líderes en el campo. Así, avanzamos en la prevención y tratamiento óptimos de la enfermedad renal y sus complicaciones.
Join our mission!
If you are interested in collaborating with us or would like more information about our lines of research, please do not hesitate to contact us. Together, we can make a difference in the lives of millions of people struggling with kidney disease.
